IFNA1 and COVID-19: These findings will be fundamental for designing appropriate pharmacological interventions to prevent infection with SARS-CoV-2 or dampen the severity of COVID-19 and will help to better understand how the IFN landscape affects human immune responses to respiratory viral infections.